Xue Z[Author] - Search Results

Year	Number of Results
1962	1
1980	2
1981	2
1982	4
1983	4
1984	3
1985	5
1986	3
1987	10
1988	9
1989	6
1990	4
1991	10
1992	13
1993	9
1994	9
1995	8
1996	4
1997	8
1998	9
1999	6
2000	15
2001	10
2002	16
2003	17
2004	28
2005	36
2006	53
2007	51
2008	71
2009	70
2010	92
2011	123
2012	150
2013	148
2014	148
2015	133
2016	162
2017	174
2018	193
2019	250
2020	292
2021	372
2022	452
2023	433
2024	466
2025	488
2026	1

1

Longitudinal serum proteome mapping reveals biomarkers for healthy ageing and related cardiometabolic diseases.

Tang J, Yue L, Xu Y, Xu F, Cai X, Fu Y, Miao Z, Gou W, Hu W, Xue Z, Deng K, Shen L, Jiang Z, Shuai M, Liang X, Xiao C, Xie Y, Guo T, Chen YM, Zheng JS. Tang J, et al. Among authors: xue z. Nat Metab. 2025 Jan;7(1):166-181. doi: 10.1038/s42255-024-01185-7. Epub 2025 Jan 13. Nat Metab. 2025. PMID: 39805987 Free PMC article.

2

PIM1 instigates endothelial-to-mesenchymal transition to aggravate atherosclerosis.

Xue Z, Han M, Sun T, Wu Y, Xing W, Mu F, Zhang Z, Liu J, Liang X, Ling L, Wang J, Wang J, Li X, Huang B, Wang D. Xue Z, et al. Theranostics. 2025 Jan 1;15(2):745-765. doi: 10.7150/thno.102597. eCollection 2025. Theranostics. 2025. PMID: 39744686 Free PMC article.

3

The use of mindfulness-based stress reduction (MBSR) for breast cancer patients-meta-analysis.

Dong X, Liu Y, Fang K, Xue Z, Hao X, Wang Z. Dong X, et al. Among authors: xue z. BMC Psychol. 2024 Nov 1;12(1):619. doi: 10.1186/s40359-024-02092-y. BMC Psychol. 2024. PMID: 39487509 Free PMC article.

4

Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment.

Xia X, He C, Xue Z, Wang Y, Qin Y, Ren Z, Huang Y, Luo H, Chen HN, Zhang WH, Huang LB, Shi Y, Bai Y, Cai B, Wang L, Zhang F, Qian M, Zhang W, Shu Y, Yin G, Xu H, Xie Q. Xia X, et al. Among authors: xue z. Nat Commun. 2025 Mar 4;16(1):2152. doi: 10.1038/s41467-025-57361-0. Nat Commun. 2025. PMID: 40038288 Free PMC article.

5

Integrative mapping of human CD8⁺ T cells in inflammation and cancer.

Xue Z, Wu L, Tian R, Gao B, Zhao Y, He B, Sun D, Zhao B, Li Y, Zhu K, Wang L, Yao J, Liu W, Lu L. Xue Z, et al. Nat Methods. 2025 Feb;22(2):435-445. doi: 10.1038/s41592-024-02530-0. Epub 2024 Nov 29. Nat Methods. 2025. PMID: 39614111

6

Effectiveness and safety of tofacitinib versus calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort study.

Wu W, Guo B, Sun W, Chen D, Xu W, Chen Z, Fu Y, Ye Y, Lyu X, Xue Z, Wang K, Zhao J, Xie C, Chen Y, Ye C, Dai M, Fan W, Li J, Wang X, Xue Y, Wan W, Sun L, Wu H, Luo Q, Han Q, Fu Q, Ye S. Wu W, et al. Among authors: xue z. Eur Respir J. 2025 May 22;65(5):2401488. doi: 10.1183/13993003.01488-2024. Print 2025 May. Eur Respir J. 2025. PMID: 39884766 Free PMC article.

7

Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis: A Randomized Clinical Trial.

Liu T, Wang L, Zhang X, Chen L, Liu Y, Jiang Z, Shuai Z, Zhang M, Wei W, Liu H, Xu J, Zhang Z, Wang G, Wang X, Hu J, Li H, Zhang Z, Wang H, Lu F, Du Y, Xue Z, Zhao Y, Li Z. Liu T, et al. Among authors: xue z. JAMA Netw Open. 2025 May 1;8(5):e2511095. doi: 10.1001/jamanetworkopen.2025.11095. JAMA Netw Open. 2025. PMID: 40388166 Free PMC article. Clinical Trial.

8

Enhanced glycolysis-derived lactate promotes microglial activation in Parkinson's disease via histone lactylation.

Qin Q, Wang D, Qu Y, Li J, An K, Mao Z, Li J, Xiong Y, Min Z, Xue Z. Qin Q, et al. Among authors: xue z. NPJ Parkinsons Dis. 2025 Jan 3;11(1):3. doi: 10.1038/s41531-024-00858-0. NPJ Parkinsons Dis. 2025. PMID: 39753581 Free PMC article.

9

Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway.

Xue Z, Liu J, Xing W, Mu F, Wu Y, Zhao J, Liu X, Wang D, Wang J, Li X, Wang J, Huang B. Xue Z, et al. J Nanobiotechnology. 2024 Oct 16;22(1):628. doi: 10.1186/s12951-024-02888-5. J Nanobiotechnology. 2024. PMID: 39407269 Free PMC article.

10

SHR-A1811, a novel anti-HER2 antibody-drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles.

Zhang T, Xu J, Yin J, Gao Y, Zheng H, Fu B, Sun J, Xu Z, Tu S, Mao Y, Wen W, Qu B, You L, Xue Z, Sun X, Cao D, Feng J, Hu M, He F. Zhang T, et al. Among authors: xue z. PLoS One. 2025 Jun 26;20(6):e0326691. doi: 10.1371/journal.pone.0326691. eCollection 2025. PLoS One. 2025. PMID: 40569929 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,103 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,103 results

Results by year